Treatment of Juvenile Myoclonic Epilepsy with Myoclonic Seizures in Children Younger Than 16
Clinical Scenario
This protocol addresses juvenile myoclonic epilepsy in children younger than 16 years of age who are experiencing myoclonic seizures. The combination of this age group and seizure pattern defines the specific population and shapes the management approach.
Treatment Approach — Partial Overview
For cases where seizures are not adequately controlled, this protocol turns to non-pharmacologic interventions. Several distinct approaches may be considered depending on clinical circumstances — the full protocol defines which applies and under what conditions.
- Decreased frequency or elimination of seizures
References
- Children (younger than 16 years)
- Myoclonic
- Up to 30% of patients with epilepsy can have medically refractory epilepsy.
- For patients with seizures that are not controlled with these agents, alternative treatments include surgical resection of the seizure focus, ketogenic diets, vagus nerve stimulators, and implantable brain neurostimulators.
- Surgical resection of the seizure focus in appropriately selected patients often results in decreased frequency or elimination of seizures with improvement in quality of life.
View source ↗